264 related articles for article (PubMed ID: 19682619)
21. Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow.
Vitaliti G; Praticò AD; Cimino C; Di Dio G; Lionetti E; La Rosa M; Leonardi S
World J Gastroenterol; 2013 Feb; 19(6):838-45. PubMed ID: 23430309
[TBL] [Abstract][Full Text] [Related]
22. Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants.
Hu Y; Wu Q; Xu B; Zhou Z; Wang Z; Zhou YH
Vaccine; 2008 Nov; 26(48):6064-7. PubMed ID: 18812198
[TBL] [Abstract][Full Text] [Related]
23. Immune response to vaccines in children with celiac disease.
Anania C; Olivero F; Spagnolo A; Chiesa C; Pacifico L
World J Gastroenterol; 2017 May; 23(18):3205-3213. PubMed ID: 28566880
[TBL] [Abstract][Full Text] [Related]
24. Factors associated with incomplete vaccination of babies at risk of perinatal hepatitis B transmission: a London study in 2006.
Giraudon I; Permalloo N; Nixon G; Charlett A; Cohuet S; Mandal S; Ramsay M; Patel BC; Maguire H
Vaccine; 2009 Mar; 27(14):2016-22. PubMed ID: 19135494
[TBL] [Abstract][Full Text] [Related]
25. [Immune effects of three different programs for revaccination among adults of non- and hypo-responders to hepatitis B vaccine].
Lin CS; Wang XY; Chen HX; Lee WH; He HT; Gao ZL
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):37-40. PubMed ID: 19534878
[TBL] [Abstract][Full Text] [Related]
26. Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed.
Prescrire Int; 2008 Dec; 17(98):234-6. PubMed ID: 19422145
[TBL] [Abstract][Full Text] [Related]
27. Role of gluten intake at the time of hepatitis B virus vaccination in the immune response of celiac patients.
Zingone F; Capone P; Tortora R; Rispo A; Morisco F; Caporaso N; Imperatore N; De Stefano G; Iovino P; Ciacci C
Clin Vaccine Immunol; 2013 May; 20(5):660-2. PubMed ID: 23446217
[TBL] [Abstract][Full Text] [Related]
28. Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan.
Kao JT; Wang JH; Hung CH; Yen YH; Hung SF; Hu TH; Lee CM; Lu SN
Vaccine; 2009 Mar; 27(12):1858-62. PubMed ID: 19186203
[TBL] [Abstract][Full Text] [Related]
29. A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting.
Sangfelt P; Uhnoo I; Reichard O; Weiland O
Scand J Gastroenterol; 2008; 43(4):465-72. PubMed ID: 18365912
[TBL] [Abstract][Full Text] [Related]
30. [Field epidemiological and experimental study on relationship between genetic factor and nonresponse or hyporesponse to hepatitis B vaccine].
Liu P; Xu H; Wang X; Li H; Zhuang G; Wu Z; Zhang K
Chin Med J (Engl); 2000 Jun; 113(6):547-50. PubMed ID: 11775878
[TBL] [Abstract][Full Text] [Related]
31. Responsiveness of children with celiac disease to different hepatitis B vaccination protocols.
Balamtekın N; Uslu N; Baysoy G; Saltik-Temızel I; Demır H; Yüce A
Turk J Gastroenterol; 2011 Feb; 22(1):27-31. PubMed ID: 21480107
[TBL] [Abstract][Full Text] [Related]
32. Persistence of hepatitis B vaccine immunity in hemodialysis patients.
Ramezani A; Velayati AA; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
Ther Apher Dial; 2008 Apr; 12(2):143-6. PubMed ID: 18387163
[TBL] [Abstract][Full Text] [Related]
33. HLA system. Phenotypic and gene frequencies in celiac and healthy subjects from the same geographical area.
Ruiz del Prado MY; Olivares López JL; Lázaro Almarza A; Lasierra Díaz MP
Rev Esp Enferm Dig; 2001 Feb; 93(2):106-13. PubMed ID: 11471223
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B vaccine administered by intradermal route in patients with celiac disease unresponsive to the intramuscular vaccination schedule: a pilot study.
Leonardi S; Del Giudice MM; Spicuzza L; Spina M; La Rosa M
Am J Gastroenterol; 2010 Sep; 105(9):2117-9. PubMed ID: 20818367
[No Abstract] [Full Text] [Related]
35. Development of multiple sclerosis after vaccination against hepatitis B: a study based on human leucocyte antigen haplotypes.
Ozakbas S; Idiman E; Yulug B; Pakoz B; Bahar H; Gulay Z
Tissue Antigens; 2006 Sep; 68(3):235-8. PubMed ID: 16948644
[TBL] [Abstract][Full Text] [Related]
36. New approaches in hepatitis B vaccination for celiac disease.
Filippelli M; Lionetti E; Pulvirenti A; Gennaro A; Lanzafame A; Marseglia GL; Salpietro C; Rosa ML; Leonardi S
Immunotherapy; 2014; 6(8):945-52. PubMed ID: 25313572
[TBL] [Abstract][Full Text] [Related]
37. Release potency tests of hepatitis vaccines.
Descamps J; Mary A; Rommel E; Anhoury ML; De Neys R; Duchêne M
Dev Biol Stand; 1999; 101():289-94. PubMed ID: 10566803
[TBL] [Abstract][Full Text] [Related]
38. The evaluation of immune responses to hepatitis B vaccination in diabetic and non-diabetic haemodialysis patients and the use of tetanus toxoid.
Ocak S; Eskiocak AF
Nephrology (Carlton); 2008 Dec; 13(6):487-91. PubMed ID: 18331434
[TBL] [Abstract][Full Text] [Related]
39. Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles.
Pietzak MM; Schofield TC; McGinniss MJ; Nakamura RM
Clin Gastroenterol Hepatol; 2009 Sep; 7(9):966-71. PubMed ID: 19500688
[TBL] [Abstract][Full Text] [Related]
40. HLA types in Turkish children with celiac disease.
Kuloğlu Z; Doğanci T; Kansu A; Demirçeken F; Duman M; Tutkak H; Ensari A; Girgin N
Turk J Pediatr; 2008; 50(6):515-20. PubMed ID: 19227412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
